Cancer Cytopathology

Aims & Scope

Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines.

The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content.

The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.2
2024	2.60

Journal Rank

Year	Value
2024	3461

Journal Citation Indicator

Year	Value
2024	989

SJR (SCImago Journal Rank)

Year	Value
2024	1.220

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	74

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology

  Citation: 255

  Authors: William C., Lawrence Q., Amir H., Syed Z., Justin A., Massimo, Marc P., Christopher J., Jolanta, Louis J., Zubair W.

• The Pap test and Bethesda 2014

  Citation: 247

  Authors: Ritu, David C.

• Contribution of molecular testing to thyroid fine‐needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”

  Citation: 211

  Authors: N. Paul, Marina N., Karen E., Shane O., Steven P., Raja R., Sally E., Jennifer B., Linwah, Yuri E.

• <i>EGFR</i> and <i>KRAS</i> mutations in lung carcinoma

  Citation: 193

  Authors: Shahreen, John, Gregg, Su, Yun, Ming

• p16/ki‐67 dual‐stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology

  Citation: 189

  Authors: Dietmar, Christine, Karin J, Ruediger

• Anal cancer and cervical cancer screening: Key differences

  Citation: 178

  Authors: Teresa M., Barbara

• The indeterminate thyroid fine‐needle aspiration

  Citation: 176

  Authors: Ritu, Marina

• Biospecimen reporting for improved study quality (BRISQ)

  Citation: 173

  Authors: Helen M., Andrea B., Scott D., Lisa M., Douglas P., Renata, Daniel F., Pierre, Paula, Elizabeth A., Olga, Peter, Yaffa, Edward, Stella, Peter, Heinz‐Ulrich, Claire, Jim

• PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens

  Citation: 156

  Authors: Jonas J., William A., David, Carlos A., John P., Mehrvash, Ladan, Mark B., Joshua R., Adrian G., Catherine A., Naiyer A., Anjali

• The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey

  Citation: 155

  Authors: Esther Diana, William C., Zubair, Güliz A., Maria Pia, Marc, Philippe, Daniel F. I.

---